REBAMIPIDE SOLUTION AS A NOVEL SUBMUCOSAL INJECTION PROMOTES HEALING SPEED AND QUALITY OF ESD-INDUCED ULCER BY SUPRESSING FIBROSIS.
Ai Fujimoto 1
Toshihiro Nishizawa 2
Masayuki Shimoda 3
Osamu Goto 2
Yasutoshi Ochiai 4
Tadateru Maehata
Teppei Akimoto
Yutaka Mitsunaga
Motohiko Kato
Atsushi Nakayama
Motoki Sasaki
Toshio Uraoka
Naohisa Yahagi
1 Keio University,Development of Minimally,Tokyo,Japan
2 Keio University,Division of Research and Development for Minimally Invasive Treatment, Cancer center,Tokyo,Japan
3 Keio University,Department of pathology,Tokyo,Japan
4 Ke
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu